| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034023090 |
| P356 | DOI | 10.1038/SJ.ONC.1204261 |
| P698 | PubMed publication ID | 11360187 |
| P2093 | author name string | F Blasi | |
| S Orlando | |||
| S A Rabbani | |||
| B Degryse | |||
| M Resnati | |||
| P2860 | cites work | The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin | Q24310652 |
| Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells | Q28142061 | ||
| The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors | Q28243582 | ||
| Role of vitronectin and its receptors in haemostasis and vascular remodeling | Q28272554 | ||
| Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration | Q28610258 | ||
| Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner | Q30304130 | ||
| Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc compl | Q30305582 | ||
| Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility | Q30471919 | ||
| Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. | Q31506532 | ||
| Bidirectional signaling between the cytoskeleton and integrins | Q33597380 | ||
| Growth factor activation of MAP kinase requires cell adhesion. | Q33887464 | ||
| A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. | Q33887878 | ||
| Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. | Q34026314 | ||
| Novel purification of vitronectin from human plasma by heparin affinity chromatography. | Q34660214 | ||
| alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor | Q36236343 | ||
| Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? | Q36237406 | ||
| Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors | Q36257661 | ||
| Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. | Q36401755 | ||
| Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model | Q37354110 | ||
| The inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the alphavbeta3 integrin complex is reversed by activated calcium/calmodulin- dependent protein kinase II. | Q37370751 | ||
| Phosphatidylinositol 3-kinase | Q40702617 | ||
| Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function | Q40890085 | ||
| Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin | Q40893088 | ||
| Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction | Q41027822 | ||
| Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect | Q41064411 | ||
| Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation | Q41113160 | ||
| Regulation of integrin function by the urokinase receptor | Q41168373 | ||
| uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? | Q41591661 | ||
| Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells | Q41592577 | ||
| Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes | Q42163142 | ||
| Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix | Q42454200 | ||
| Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling | Q42478267 | ||
| Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase | Q42797515 | ||
| Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils | Q43881611 | ||
| Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. | Q45555792 | ||
| Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration | Q46797055 | ||
| Beta3-integrins rather than beta1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration | Q48035533 | ||
| The urokinase receptor is a major vitronectin-binding protein on endothelial cells | Q71034141 | ||
| Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA | Q71608650 | ||
| Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis | Q71675475 | ||
| Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor | Q72089738 | ||
| Cell-surface acceleration of urokinase-catalyzed receptor cleavage | Q73067924 | ||
| Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system | Q73209090 | ||
| Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction | Q74338845 | ||
| Insulin, growth factors, and cAMP: antagonism in the signal transduction pathways | Q81066607 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotaxis | Q658145 |
| P304 | page(s) | 2032-2043 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways | |
| P478 | volume | 20 |
| Q40355156 | An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. |
| Q36749726 | Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice |
| Q41465764 | Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system |
| Q33933531 | CNN3 regulates trophoblast invasion and is upregulated by hypoxia in BeWo cells |
| Q40135411 | Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling |
| Q81152153 | Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) |
| Q48220228 | D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR. |
| Q61799120 | Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor |
| Q33959863 | Differences in integrin expression and signaling within human breast cancer cells |
| Q38601915 | Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells |
| Q35034871 | Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression |
| Q47188768 | Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides |
| Q37081801 | LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells |
| Q35107356 | Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion |
| Q34540644 | Multi-tissue microarray analysis identifies a molecular signature of regeneration |
| Q74535973 | PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor |
| Q83162820 | Plasminogen activator inhibitor-1: the double-edged sword in apoptosis |
| Q44222507 | Pro-collagen I COOH-terminal trimer induces directional migration and metalloproteinases in breast cancer cells |
| Q30157380 | Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells |
| Q34601099 | RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth |
| Q36321377 | Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. |
| Q24296406 | Stabilization of Urokinase and Urokinase Receptor mRNAs by HuR Is Linked to Its Cytoplasmic Accumulation Induced by Activated Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 |
| Q28570659 | The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells |
| Q35556137 | The nuclear protein HMGB1, a new kind of chemokine? |
| Q35085325 | The role of the plasminogen activation cascade in glioma cell invasion: a review. |
| Q36322653 | The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells |
| Q36908422 | The vitronectin-binding domain of plasminogen activator inhibitor-1 plays an important functional role in lipopolysaccharide-induced lethality in mice |
| Q35124141 | Urokinase and its receptors in chronic kidney disease. |
| Q35901840 | Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation |
| Q37432551 | Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer |
| Q24529131 | Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta |
| Q50692022 | uPA-uPAR molecular complex is involved in cell signaling during neuronal migration and neuritogenesis. |
| Q43951136 | uPA/PAI-1 expression and uPA promoter methylation in meningiomas |
| Q34162183 | uPAR: a versatile signalling orchestrator |
Search more.